KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Operating Expenses (2017 - 2025)

Guardant Health (GH) has disclosed Operating Expenses for 9 consecutive years, with $402.1 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 22.67% to $402.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 20.01% year-over-year, with the annual reading at $1.4 billion for FY2025, 20.01% up from the prior year.
  • Operating Expenses hit $402.1 million in Q4 2025 for Guardant Health, up from $364.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $402.1 million in Q4 2025 to a low of $186.5 million in Q1 2021.
  • Historically, Operating Expenses has averaged $275.5 million across 5 years, with a median of $265.5 million in 2023.
  • Biggest five-year swings in Operating Expenses: skyrocketed 82.12% in 2021 and later dropped 7.03% in 2024.
  • Year by year, Operating Expenses stood at $206.3 million in 2021, then skyrocketed by 32.33% to $273.0 million in 2022, then increased by 29.14% to $352.6 million in 2023, then dropped by 7.03% to $327.8 million in 2024, then grew by 22.67% to $402.1 million in 2025.
  • Business Quant data shows Operating Expenses for GH at $402.1 million in Q4 2025, $364.2 million in Q3 2025, and $338.5 million in Q2 2025.